Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Neurology
|
April 1, 1992
HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles
M G Marrosu, F Muntoni, M R Murru, et al.
Annals of Neurology
|
November 1, 1995
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells
F Zipp, F Weber, S Huber, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 27, 2002
P300 and executive function alterations: possible links in a case of Morgagni-Stewart-Morel syndrome
K S Paulus, I Magnano, I Aiello, et al.
European Review for Medical and Pharmacological Sciences
|
January 20, 2022
Corpus callosum volumetrics and clinical progression in early multiple sclerosis
M A Sotgiu, G Piga, V Mazzarello, et al.
Italian Journal of Neurological Sciences
|
April 1, 1992
Interaction of tonic labyrinth and neck reflexes in man
I Aiello, G Rosati, G F Sau, et al.
European Journal of Neurology
|
May 26, 2006
Inflammatory biomarkers in blood of patients with acute brain ischemia
S Sotgiu, B Zanda, B Marchetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2005
MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination
J Garson, A Créange, A Dolei, et al.
Journal of Neurology
|
April 11, 2007
The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcome
G C DeLuca, S V Ramagopalan, M Z Cader, et al.
Journal of Neuroimmunology
|
March 23, 2007
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis
S V Ramagopalan, G C Deluca, K M Morrison, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus
G C DeLuca, S V Ramagopalan, B M Herrera, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Neurology
|
April 1, 1992
HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles
M G Marrosu, F Muntoni, M R Murru, et al.
Annals of Neurology
|
November 1, 1995
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells
F Zipp, F Weber, S Huber, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 27, 2002
P300 and executive function alterations: possible links in a case of Morgagni-Stewart-Morel syndrome
K S Paulus, I Magnano, I Aiello, et al.
European Review for Medical and Pharmacological Sciences
|
January 20, 2022
Corpus callosum volumetrics and clinical progression in early multiple sclerosis
M A Sotgiu, G Piga, V Mazzarello, et al.
Italian Journal of Neurological Sciences
|
April 1, 1992
Interaction of tonic labyrinth and neck reflexes in man
I Aiello, G Rosati, G F Sau, et al.
European Journal of Neurology
|
May 26, 2006
Inflammatory biomarkers in blood of patients with acute brain ischemia
S Sotgiu, B Zanda, B Marchetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2005
MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination
J Garson, A Créange, A Dolei, et al.
Journal of Neurology
|
April 11, 2007
The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcome
G C DeLuca, S V Ramagopalan, M Z Cader, et al.
Journal of Neuroimmunology
|
March 23, 2007
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis
S V Ramagopalan, G C Deluca, K M Morrison, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus
G C DeLuca, S V Ramagopalan, B M Herrera, et al.
Page
of 6